An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

Project: Other project

Project Details

StatusFinished
Effective start/end date2/4/14 → 11/17/17